Primobolan

• Protein synthesis disorders
• Cachexia of diverse genesis
• Trauma, extensive burns after irradiation
• Infectious diseases
• Muscular dystrophy
• Osteoporosis
• Negative nitrogen balance corticosteroid therapy
• Hypo and aplastic anemia

• Hypersensitivity to the drug
• Prostate cancer
• Breast cancer in men
• Breast carcinoma in women with hypercalcemia
• CPI, severe atherosclerosis
• Nephrotic syndrome
• Acute and chronic liver disease
• Nephritis
• Pregnancy, lactation

The drug is administered 1 ml deep intramuscularly every 2 weeks. After the desired result is obtained, the administration of 1 ml can be done every 3–4 weeks.

Methenolone is an anabolic steroid. When entering the cell nucleus, it stimulates the genetic apparatus of the cell, leading to increased synthesis of DNA, RNA, and structural proteins. It activates tissue respiration chain enzymes and enhances tissue respiration, oxidative phosphorylation, ATP synthesis, and intracellular macroregion aggregation. It stimulates anabolic processes and inhibits the catabolic ones caused by glucocorticoids. Methenolone administration leads to increased muscle mass, reduced fat deposits, improved tissue trophism, promotes calcium deposition in bones, and retains sodium and water in the body.